Published:September 15, 2020
FOIA to FDA Seeking Email Communications Regarding Convalescent Plasma Treatment for Covid-19
FOIA request to the Food and Drug Administration seeking email communications regarding convalescent plasma therapy as a treatment for Covid-19.
HHS-FDA-20-2274